Published in Clinical Oncology Week, July 30th, 2007
"We studied renal damage in rats after therapy with different amounts Of [Lu-177- DOTA(0),Tyr(3)]octreotate and investigated Tc-99m-DMSA (dimercaptosuccinic acid) as a tool to quantify renal damage after PRRT. Experimental Twenty-nine (29) rats were divided into 3 groups and injected with either 0,278, or 555 MBq...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Oncology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.